Sanofi Can't Ditch Ex-Worker's FCA Claims Over Cancer Drug

Law360, Los Angeles (January 10, 2017, 7:01 PM EST) -- Sanofi on Monday lost a bid to dodge False Claims Act allegations that it unlawfully marketed off-label uses of a cancer drug when a Pennsylvania federal judge said there was a genuine dispute over whether the marketing was false or misleading.  

The long-running suit was filed by Yoash Gohil, who worked as an oncology sales specialist for Aventis Pharmaceuticals Inc. and its predecessors from 1982 until 2002. He alleged that the company, which changed its name to Sanofi after a merger, spent many years unlawfully marketing...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.